APA (7th ed.) Citation

Xu, X., Liu, J., Fang, C., Deng, X., Zhu, D., Jiang, J., & Wu, C. (2024). NAALADL2-AS2 functions as a competing endogenous RNA to regulate apoptosis and drug resistance in DLBCL. Cancer Biology & Therapy, 25(1), . https://doi.org/10.1080/15384047.2024.2432690

Chicago Style (17th ed.) Citation

Xu, Xiaoli, Juan Liu, Cheng Fang, Xu Deng, Danxia Zhu, Jingting Jiang, and Changping Wu. "NAALADL2-AS2 Functions as a Competing Endogenous RNA to Regulate Apoptosis and Drug Resistance in DLBCL." Cancer Biology & Therapy 25, no. 1 (2024). https://doi.org/10.1080/15384047.2024.2432690.

MLA (9th ed.) Citation

Xu, Xiaoli, et al. "NAALADL2-AS2 Functions as a Competing Endogenous RNA to Regulate Apoptosis and Drug Resistance in DLBCL." Cancer Biology & Therapy, vol. 25, no. 1, 2024, https://doi.org/10.1080/15384047.2024.2432690.